Pengbo Ning
Impact in
- Immunology top 5%
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Animal Disease Management and Epidemiology 15
- Co-authors
- Zhongliang Wang (12 shared papers)Yuqiong Xia (17 shared papers)Xiaoyuan Chen (2 shared papers)Huimin Yao (4 shared papers)Lang Rao (1 shared paper)Peng Yang (8 shared papers)Zhiping Rao (6 shared papers)Yutong Zhu (3 shared papers)
- Journals
- Colloids and Surfaces B Biointerfaces (4 papers)PLoS ONE (4 papers)PeerJ (3 papers)Journal of Controlled Release (2 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Pengbo Ning
52 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Immunology 553
- Biomaterials 251
- Cancer Research 229
- Molecular Biology 964
- Biomedical Engineering 557
Countries citing papers authored by Pengbo Ning
This map shows the geographic impact of Pengbo Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengbo Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengbo Ning more than expected).
Fields of papers citing papers by Pengbo Ning
This network shows the impact of papers produced by Pengbo Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengbo Ning. The network helps show where Pengbo Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Pengbo Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Engineering Macrophages for Cancer Immunotherapy and Drug Delivery Hit paper breakdown → | 2020 | 711 |
| 2 | Pyroptosis in inflammatory diseases and cancer Hit paper breakdown → | 2022 | 448 |
| 3 | 2022 | 109 | |
| 4 | 2022 | 103 | |
| 5 | 2019 | 64 | |
| 6 | 2013 | 53 | |
| 7 | 2018 | 41 | |
| 8 | 2018 | 40 | |
| 9 | 2015 | 39 | |
| 10 | 2016 | 38 | |
| 11 | 2024 | 32 | |
| 12 | 2018 | 32 | |
| 13 | 2023 | 28 | |
| 14 | 2016 | 28 | |
| 15 | 2013 | 25 | |
| 16 | 2015 | 22 | |
| 17 | 2017 | 22 | |
| 18 | 2015 | 20 | |
| 19 | 2024 | 19 | |
| 20 | 2019 | 16 |
About Pengbo Ning
Pengbo Ning is a scholar working on Molecular Biology, Agronomy and Crop Science, Biomedical Engineering, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 54 papers that have together received 2.1k indexed citations. Recurring topics across this work include Animal Disease Management and Epidemiology (15 papers), Nanoplatforms for cancer theranostics (14 papers), Viral Infections and Immunology Research (9 papers), Animal Virus Infections Studies (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Viral gastroenteritis research and epidemiology (7 papers), Vector-Borne Animal Diseases (5 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Immunology (553 citations), Biomaterials (251 citations), Cancer Research (229 citations), Molecular Biology (964 citations) and Biomedical Engineering (557 citations). Pengbo Ning has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Zhongliang Wang, Yuqiong Xia, Xiaoyuan Chen, Huimin Yao, Lang Rao, Peng Yang, Zhiping Rao, Yutong Zhu, Chaoqiang Qiao and Hongzhang Deng. Their work appears in journals such as Colloids and Surfaces B Biointerfaces, PLoS ONE, PeerJ, Journal of Controlled Release and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.